(Q34238238)

31 July 2017

1 reference

title

The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives (English)

1 reference

Hormone Replacement Therapy

31 July 2017

main subject

1 reference

K I Pritchard

1

1 reference

31 July 2017

publication date

1 March 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

301-310

1 reference

Measuring the impact of menopausal symptoms on quality of life

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

The prevention and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Menopause and the risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Prospective study of exogenous hormones and risk of pulmonary embolism in women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Risk of venous thromboembolism in users of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Alternatives to estrogen for menopausal women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Estrogen therapy during menopause. Practical treatment recommendations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Calcium and osteoporosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Non-pharmacological modification of cardiac risk factors: Part 1.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

NSAID use and decreased risk of gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Estrogen replacement therapy in women with breast cancer: a survey of patient attitudes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Breast cancer and pregnancy: the ultimate challenge

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Hormone replacement therapy in women treated for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Hormone replacement therapy in breast cancer survivors: a cohort study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Hormone replacement after breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Hormone replacement therapy in previously treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Estrogen replacement therapy withdrawal and regression of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Breast cancer response to hormone replacement therapy withdrawal

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Prognostic characteristics in breast cancers after hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Hormone replacement therapy and high S phase in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Transdermal clonidine for ameliorating tamoxifen-induced hot flashes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Megestrol Acetate for the Prevention of Hot Flashes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011197007606

7 January 2021

Identifiers

DOI

10.1023/A:1011197007606

1 reference

31 July 2017

1 reference